Literature DB >> 28182861

Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.

Ryoko Egashira1, Joseph Jacob1, Maria A Kokosi1, Anne-Laure Brun1, Alexandra Rice1, Andrew G Nicholson1, Athol U Wells1, David M Hansell1.   

Abstract

Purpose To investigate the prevalence of diffuse pulmonary ossification (DPO) in patients with fibrosing interstitial lung disease (ILD) and determine whether there are differences among the types of ILDs. Materials and Methods Institutional review board approval was given and patient consent was not required for this study. The study population comprised 892 consecutive patients with fibrosing ILD, including 456 patients with idiopathic pulmonary fibrosis (IPF) (men, 366; women, 90; median age, 72 years [range, 38-93 years]), 244 with nonspecific interstitial pneumonia (men, 79; women, 165; median age, 60.5 years [range, 23-86 years]), and 192 with chronic hypersensitivity pneumonitis (men, 76; women, 116; median age, 66 years [range, 35-88 years]). Pulmonary ossifications were recorded when nodules (<4 mm diameter) were identified on bone window images (width, 2500 HU; level, 500 HU). DPO was defined as 10 or more bilateral nodular ossifications (definition 1) or as one or more lobes with five or more bilateral nodular ossifications (definition 2). Relationships among pulmonary ossification and parenchymal patterns, clinical parameters, and multidisciplinary team diagnoses were examined. The prevalence of DPO was compared with the χ2 statistic or Fisher exact test, and multivariate analysis was performed with logistic regression. Results In the whole population, the prevalence of DPO was 166 (18.6%) and 106 (11.9%) of 892 patients according to definitions 1 and 2, respectively. The prevalence of DPO (definition 1) was significantly higher in patients with IPF (28.5%) than in those without IPF (8.3%, P < .001). Nine of 192 (4.7%) had chronic hypersensitivity pneumonitis (P < .001), and 27 of 244 (11.1%) had nonspecific interstitial pneumonia (P < .001). At multivariate analysis, DPO according to definition 1 was an independent predictor of IPF diagnosis (P < .001) and male sex (P = .003). Coarseness of fibrosing ILD (P = .011) and IPF diagnosis (P = .016) were independently associated with pulmonary ossification profusion. Conclusion DPO is common in patients with fibrosing ILD and is significantly more prevalent in patients with IPF than in those with other fibrosing ILDs, and thus, computed tomographic signs of DPO may be helpful for diagnosis of IPF. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2017        PMID: 28182861     DOI: 10.1148/radiol.2017152419

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.

Authors:  Hidemasa Matsuo; Tomohiro Handa; Michiko Tsuchiya; Takeshi Kubo; Akihiko Yoshizawa; Yuko Nakayama; Shuichi Shiga; Takefumi Hitomi; Souichi Adachi; Hiroshi Date; Toyohiro Hirai; Satoshi Ichiyama
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

2.  Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.

Authors:  Monica Palermo; Francesco Tiralongo; Giulio Distefano; Ada Vancheri; Mauro Giuffrè; Fabio Pino; Pietro Valerio Foti; Gianluca Sambataro; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2021-01-12

3.  Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties.

Authors:  Barbara Orzechowska; Kamil Awsiuk; Dawid Wnuk; Joanna Pabijan; Tomasz Stachura; Jerzy Soja; Krzysztof Sładek; Joanna Raczkowska
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

4.  Nothing but lung and bones: Longitudinal evolution and quantitative analysis in a case of idiopathic diffuse pulmonary ossification.

Authors:  Aldo Carnevale; Serena Chiarello; Giovanni Lanza; Alberto Cossu; Melchiore Giganti; Brunilda Marku
Journal:  Radiol Case Rep       Date:  2022-02-20

5.  Malfunction of airway basal stem cells plays a crucial role in pathophysiology of tracheobronchopathia osteoplastica.

Authors:  Yue Hong; Shan Shan; Ye Gu; Haidong Huang; Quncheng Zhang; Yang Han; Yongpin Dong; Zeyu Liu; Moli Huang; Tao Ren
Journal:  Nat Commun       Date:  2022-03-14       Impact factor: 17.694

6.  Dendriform pulmonary ossification in coronavirus disease 2019 pneumonia.

Authors:  Pedro Paulo Teixeira E Silva Torres; Marcelo Fouad Rabahi; Edson Marchiori
Journal:  Rev Soc Bras Med Trop       Date:  2022-03-14       Impact factor: 1.581

Review 7.  Differential diagnoses of fibrosing lung diseases.

Authors:  Carolyn Horst; Bahareh Gholipour; Arjun Nair; Joseph Jacob
Journal:  BJR Open       Date:  2019-06-13

8.  Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma.

Authors:  Pattamon Sutthatarn; Cara E Morin; Jessica Gartrell; Wayne L Furman; Max R Langham; Teresa Santiago; Andrew J Murphy
Journal:  Children (Basel)       Date:  2021-03-16

9.  Dendriform Pulmonary Ossification: Findings from Eight Years of Observation.

Authors:  Takehiro Tsuchiya; Makoto Tanaka
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

Review 10.  A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease.

Authors:  Christopher J Ryerson; Tamera J Corte; Jeffrey L Myers; Simon L F Walsh; Sabina A Guler
Journal:  Eur Respir J       Date:  2021-12-16       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.